Skip to main content
TheozPEPTIDES
· 4 min read

Tirzepatide vs Semaglutide in Bali: What the Trial Shows

Read the head-to-head tirzepatide and semaglutide findings, understand their limits and compare the tirzepatide pen formats listed by Theoz in Bali.

An empty training space, illustrating the wider context of weight-management research.
Illustrative stock photograph; it does not depict the supplied product or a treatment outcome. Photo: 大 董 / Pexels.

Tirzepatide produced greater average weight reduction than semaglutide in the SURMOUNT-5 trial, which compared the two in adults with obesity without diabetes over 72 weeks. That is a meaningful research result. It does not mean every person will obtain the average result, or that every pen bearing an ingredient name is the branded product used in the trial.

If you are researching tirzepatide vs semaglutide in Bali, start with that distinction. It lets you separate the scientific comparison from a second, practical comparison: which product, presentation and documentation a local seller actually offers. Both deserve a clear answer before an order.

Tirzepatide vs semaglutide: the receptor difference

Semaglutide acts at the GLP-1 receptor. Tirzepatide acts at both GIP and GLP-1 receptors. These pathways are involved in appetite and metabolic regulation, which explains why the compounds often appear in the same discussion. The official tirzepatide prescribing information describes its dual-receptor activity and the clinical conditions in which that branded medicine is used.

Two receptor targets do not automatically mean twice the benefit. Receptor biology gives a reason to investigate a compound; clinical trials measure what actually happens in a particular population. The most useful evidence here comes from studying both treatments within the same trial rather than putting numbers from unrelated studies side by side.

What SURMOUNT-5 measured

The published SURMOUNT-5 report included 751 participants. Treatment was open-label, and the analysis compared changes in weight and waist circumference after 72 weeks. Both groups used the trial's treatment and follow-up framework.

Mean change at week 72TirzepatideSemaglutide
Body weight−20.2%−13.7%
Waist circumference−18.4 cm−13.0 cm

These are group averages in adults with obesity without diabetes. Gastrointestinal events were the most common adverse events in both groups, generally mild to moderate and concentrated during escalation. The study was funded by Eli Lilly. Its findings support a comparison within that study design, not a guarantee for a buyer in Bali.

How to read the percentage difference correctly

The difference between 20.2% and 13.7% is 6.5 percentage points. Calling that “6.5% more weight loss” would blur two different calculations. Relative percentage comparisons can sound much larger, which is why the actual two group results should stay visible.

Also check the denominator in any headline. A percentage of starting body weight is different from a percentage change in waist circumference or fat mass. If a social post combines those endpoints into one ranking, return to the study table before drawing a conclusion. Clear units make the comparison more useful than a dramatic slogan.

What this means for a local product search

Theoz lists Tirzepatide 30 mg and 60 mg prefilled pens. The catalogue prices are IDR 3,500,000 and IDR 5,400,000 respectively. Those are the total contents and prices of the listed presentations. They are not the weekly treatment amounts from SURMOUNT-5 and should not be read as treatment instructions.

Theoz does not list semaglutide in its current collection. This article therefore explains a research comparison; it is not an offer for two locally stocked products. To inspect the available tirzepatide variants, open the Tirzepatide product page and check the selected format before adding it to the bag.

Build a comparison you can actually use

Write down the question you want the research to answer: weight change, appetite, tolerability or an existing clinical plan. Then keep a separate list of purchasing questions. This prevents a strong ingredient-level result from concealing uncertainty about the product being supplied.

  • Record the exact ingredient and total pen contents.
  • Confirm the manufacturer and product documentation for that presentation.
  • Compare the complete IDR total, including delivery where applicable.
  • Check that the product and device instructions match an established treatment plan.
  • Confirm the receiving address and availability with the Bali team.

For a villa in Umalas or a hotel in Seminyak, a clear map pin and a reachable recipient help the delivery conversation. They do not change the findings of the trial. Keep the scientific and logistical questions connected, while allowing each to be answered by the right source.

Questions buyers ask

Does the trial show that tirzepatide is best for everyone?

No. It found a greater average change in the studied outcomes and population. Individual suitability also depends on medical history, other treatments, tolerability and the actual medicine supplied. A clinician can interpret that combination; a catalogue comparison cannot replace it.

Where should I start with Theoz?

Compare the two tirzepatide pen formats and the 30 mg vs 60 mg explanation. Send the team the selected format and quantity for a precise Bali quote. The useful next step is a clearly identified order, supported by an informed treatment decision.

Explore the products

WhatsApp

Your bag

Review your selection, then continue to checkout to save your Bali order.

Items total IDR 0

0 physical pens · Free delivery from 3 pens.

Bali delivery—
TotalIDR 0
Continue to checkout ↗